News
OpenAI and the U.S. Food and Drug Administration have been meeting to discuss the health regulator's use of AI, technology ...
U.S. President Donald Trump is expected to sign an executive order as early as next week that would revive an effort to ...
The U.S. Food and Drug Administration said on Wednesday it will hold a meeting of experts to discuss COVID-19 vaccine ...
(Reuters) -A U.S. federal judge has sided with a U.S. regulator's decision last year to take Eli Lilly’s blockbuster weight ...
WEDNESDAY, May 7, 2025 (HealthDay News) — The official in charge of federal food and drug safety inspections will retire May ...
A salsa product recalled in April due to the possible presence of wood has now been issued a Class II risk classification by ...
WASHINGTON (AP) — Dr. Vinay Prasad, a prominent critic of the pharmaceutical industry and the Food and Drug Administration, ...
High-ranking OpenAI employees have met with the FDA multiple times in recent weeks to discuss AI and a project called cderGPT ...
OpenAI has reportedly met with officials from the Food and Drug Administration to discuss how AI could speed up drug ...
The FDA's decision to appoint Vinay Prasad, MD, MPH, to head its Center for Biologics Evaluation and Research (CBER) raised ...
Dr. Vinay Prasad, the FDA's new vaccine chief, has been accused of spreading misinformation about Covid vaccines.
A new federal ruling means that patients will no longer have access to cheaper versions of Eli Lilly weight loss and diabetes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results